Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Dancing away Parkinson's symptoms: tango therapy put to the test

NCT ID NCT07736014

Symptom relief Sponsor: University of Foggia Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This trial investigates whether structured tango therapy can improve motor function, balance, and quality of life in people with mild to moderate Parkinson's disease. Participants are assigned to tango sessions, a standard motor reconditioning program, or a control group. Over three months of intervention and three months of follow-up, researchers measure changes in movement, gait, and daily function to see if dance offers unique benefits beyond conventional exercise.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
tango therapy and motor reconditioning programs
What this could lead to
If tango therapy proves effective, it could offer a fun, social exercise option to help manage motor symptoms and balance in Parkinson's disease.
What could go wrong
This is a small, early-stage trial with only 27 participants, so results may not apply widely. The benefits of dance therapy may be modest and require further study.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

27 people

The number who actually took part.

Started

Oct 2024

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Confirmed clinical diagnosis of idiopathic Parkinson's Disease. * Mild to moderate disease severity (Hoehn and Yahr stage I-III). * Ability to walk independently (with or without assistive devices). * Stable antiparkinsonian pharmacological treatment for at least 4 weeks prior to enrollment. * Ability to understand study procedures and willingness to sign the Informed Consent document. Exclusion Criteria: * Severe cognitive impairment or dementia preventing comprehension of instructions or active participation. * Severe cardiovascular, respiratory, orthopedic, or other neurological conditions that impair safe exercise participation or gait evaluation. * Surgical interventions that directly affect mobility or dynamic balance (e.g., Deep Brain Stimulation or recent major orthopedic surgery). * Concurrent participation in other physical rehabilitation programs or clinical trials during the study period.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Parkinson's disease (PD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Parkinson's disease (PD)

Contacts and locations

Locations

  • Azienda Ospedaliero-Universitaria "Ospedali Riuniti" di Foggia

    Foggia, FG, 71122, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.